Drug Type CAR-T |
Synonyms- |
Target |
Action agonists, modulators |
Mechanism 4-1BBL agonists(Tumor necrosis factor ligand superfamily member 9 agonists), CD276 modulators(CD276 antigen modulators), OX40L agonists(Tumor necrosis factor ligand superfamily member 4 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Preclinical | China | 30 May 2025 |